Literature DB >> 19919805

The burden of psoriasis and barriers to satisfactory care: results from a Canadian patient survey.

Ronald Mahler1, Christine Jackson, Horia Ijacu.   

Abstract

BACKGROUND: The physical, mental, social, and financial burdens experienced by Canadians with psoriasis are relatively unexplored.
OBJECTIVE: To gain an understanding of the impact of psoriasis on Canadians.
METHODS: An online survey, "Stand Up and Speak Out," was provided to Psoriasis Education Program users who had given consent to be contacted.
RESULTS: Ninety-five percent of respondents had moderate to severe psoriasis, a high proportion relative to similar studies. Respondents reported medical and psychological comorbidities, with prevalence up to fourfold higher than Canadian background rates. Respondents also reported reduced income and increased unemployment, at levels that increased with psoriasis severity. Use of biologics was associated with high levels of satisfaction relative to other treatment options. However, biologic use was not uniform but was strongly correlated with insured status and annual income.
CONCLUSION: In this severely affected population of Canadians with psoriasis, the physical, mental, social, and financial burden of disease was high.

Entities:  

Mesh:

Year:  2009        PMID: 19919805     DOI: 10.2310/7750.2009.08083

Source DB:  PubMed          Journal:  J Cutan Med Surg        ISSN: 1203-4754            Impact factor:   2.092


  7 in total

1.  How psoriasis patients perceive, obtain, and use biologic agents: Survey from an academic medical center.

Authors:  Faranak Kamangar; Leah Isip; Tina Bhutani; Madison Dennis; Misha M Heller; Eric S Lee; Hong Nie; Wilson Liao
Journal:  J Dermatolog Treat       Date:  2011-11-10       Impact factor: 3.359

2.  Evaluating practice patterns for managing moderate to severe plaque psoriasis: role of the family physician.

Authors:  Yves Poulin; Norman Wasel; Daphne Chan; Geula Bernstein; Robin Andrew; Elisa Fraquelli; Kim Papp
Journal:  Can Fam Physician       Date:  2012-07       Impact factor: 3.275

3.  Predictors of biologic treatment of psoriasis: a non-interventional study.

Authors:  Luis Puig; Tao Fan; Qian Ding; Nancy E Smith
Journal:  Clinicoecon Outcomes Res       Date:  2014-02-17

Review 4.  A patient-centred approach to biological treatment decision making for psoriasis: an expert consensus.

Authors:  R Strohal; J C Prinz; G Girolomoni; A Nast
Journal:  J Eur Acad Dermatol Venereol       Date:  2015-09-14       Impact factor: 6.166

5.  Sex Differences in the Patterns of Systemic Agent use Among Patients With Psoriasis: A Retrospective Cohort Study in Quebec, Canada.

Authors:  Raymond Milan; Jacques LeLorier; Marie-Josée Brouillette; Anne Holbrook; Ivan V Litvinov; Elham Rahme
Journal:  Front Pharmacol       Date:  2022-02-15       Impact factor: 5.810

6.  Psoriatic Dermal-Derived Mesenchymal Stem Cells Induced C3 Expression in Keratinocytes.

Authors:  Aihong Peng; Funa Lu; Jianxiao Xing; Yu Dou; Yuanjun Yao; Juan Li; Junqin Li; Ruixia Hou; Kaiming Zhang; Guohua Yin
Journal:  Clin Cosmet Investig Dermatol       Date:  2022-08-02

7.  Efficacy and safety of JAK inhibitors in the treatment of psoriasis and psoriatic arthritis: a systematic review and meta-analysis.

Authors:  Samantha Sarabia; Brandan Ranjith; Sahil Koppikar; Don Thiwanka Wijeratne
Journal:  BMC Rheumatol       Date:  2022-09-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.